Journal Logo

February 2019 - Volume 30 - Issue 2
pp: 117-208

Cytotoxicity and molecular activity of fenretinide and metabolites in T-cell lymphoid malignancy, neuroblastoma, and ovarian cancer cell lines in physiological hypoxia

Song, Michael M.; Makena, Monish R.; Hindle, Ashly; More

Anti-Cancer Drugs. 30(2):117-127, February 2019.

Four lines of anaplastic lymphoma kinase inhibitors and brain radiotherapy in a long-surviving non-small-cell lung cancer anaplastic lymphoma kinase-positive patient with leptomeningeal carcinomatosis

Onesti, Concetta E.; Iacono, Daniela; Angelini, Silvia; More

Anti-Cancer Drugs. 30(2):201-204, February 2019.

Myeloablative chemotherapy and autologous stem cell transplantation can lead to successful postengraftment mobilization of hematopoietic progenitors to support planned subsequent cycle(s) of high-dose chemotherapy and autografting in a patient with relapsed germ-cell tumor

Fergadis, Evangelos; Gavrielatou, Niki; Skouteris, Nikos; More

Anti-Cancer Drugs. 30(2):205-208, February 2019.